- Home
- / Arbor Biotechnologies
Arbor Biotechnologies
Total Funding
$215 M
Arbor Biotechnologies Summary
Company Summary
- Overview
- Arbor Biotechnologies is a company that provides genetic medicines for genetic diseases. It offers in discovery science, DNA sequencing and synthesis, bioengineering, molecular biology, biochemistry, and protein biology services.
- Type
- Private
- Status
- Active
- Founded
- 2016
- HQ
- Cambridge, MA, US | view all locations
- Website
- https://arbor.bio/
- Cybersecurity rating
Table of Contents
Key People
Greg Hoffman, Vice President Discovery & Platform
Peng Meng Kou, Associate Director, Corporate Development & New Product Planning
John Murphy, Chief Scientific Officer
